Daily intake of 0.4 grams of omega-3 could help more than 95% of diabetics achieve desirable blood sugar levels, according to a Chinese study based on population pharmacokinetic-pharmacodynamic (PPK-PD) modelling.
Australia’s BiomeMega says its probiotic-derived Omega-3 comes with additional functional benefits, higher bioavailability, and can be produced at a large scale via precision fermentation.
Eicosapentaenoic acid (EPA) alone, and not combined with docosahexaenoic acid (DHA), reduced the risk of cardiovascular diseases in diabetic patients, according to a new Chinese study.
Seafood-based Omega-3 intake has been linked with a reduced incidence of chronic kidney disease, but no such association was found for plant-based sources.
